Dual roles of immunoregulatory cytokine TGF-β in the pathogenesis of autoimmunity-mediated organ damage

Journal of Immunology

Volumn 180, Issue 3, 2008, Pages 1903-1912

  Saxena, Vijay ^b   Lienesch, Douglas W ^b   Zhou, Min ^a   Bommireddy, Ramireddy ^b,c   Azhar, Mohamad ^b,c   Doetschman, Thomas ^b,c   Singh, Ram Raj ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; MESSENGER RNA; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBROGENESIS; IMMUNE DYSREGULATION; IMMUNE MEDIATED INJURY; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IN VIVO STUDY; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; LYMPHOID TISSUE; MALE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TISSUE INJURY; TISSUE REPAIR; URINE; ANIMAL; FIBROSIS; GENETICS; IMMUNOLOGY; KIDNEY; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FIBROSIS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOID TISSUE; MICE; MICE, MUTANT STRAINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 40749089639     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.3.1903     Document Type: Article

References (42)

1. Davidson, A., and B. Diamond. 2001. Autoimmune diseases. N. Engl. J. Med. 345: 340-350.
2. Singh, R. R. 2005. SLE: translating lessons from model systems to human disease. Trends Immunol. 26: 572-579.
3. Niculescu, F., P. Nguyen, T. Niculescu, H. Rus, V. Rus, and C. S. Via. 2003. Pathogenic T cells in murine lupus exhibit spontaneous signaling activity through phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. Arthritis Rheum. 48: 1071-1079.
4. + T cells from lupus-prone mice avoid antigen-specific tolerance induction in vivo. J. Immunol. 170: 741-748.
5. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
6. Kulkarni, A. B., C. G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. 1993. Transforming growth factor β 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770-774.
7. Bommireddy, R., V. Saxena, I. Ormsby, M. Yin, G. P. Boivin, G. F. Babcock, R. R. Singh, and T. Doetschman. 2003. TGF-β 1 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes. J. Immunol. 170: 4612-4622.
8. Dang, H., A. G. Geiser, J. J. Letterio, T. Nakabayashi, L. Kong, G. Fernandes, and N. Talal. 1995. SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-β knockout mice. J. Immunol. 155: 3205-3212.
9. Bommireddy, R., L. J. Pathak, J. Martin, I. Ormsby, S. J. Engle, G. P. Boivin, G. F. Babcock, A. U. Eriksson, R. R. Singh, and T. Doetschman. 2006. Self-antigen recognition by TGF-β1-deficient T cells causes their activation and systemic inflammation. Lab. Invest. 86: 1008-1019.
10. Adams, D. E., J. Q. Yang, and R. R. Singh. 2004. Conditional TGF-β receptor II deletion in murine thymocytes results in spontaneous T cell activation and multiorgan inflammation. FASEB J. 18: A1136.
11. Li, M. O., S. Sanjabi, and R. A. Flavell. 2006. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25: 455-471.
12. Marie, J. C., D. Liggitt, and A. Y. Rudensky. 2006. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity 25: 441-454.
13. Ohtsuka, K., J. D. Gray, M. M. Stimmler, B. Toro, and D. A. Horwitz. 1998. Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 160: 2539-2545.
14. Grande, J. P. 1998. Mechanisms of progression of renal damage in lupus nephritis: pathogenesis of renal scarring. Lupus 7: 604-610.
15. Strutz, F., and E. G. Neilson. 2003. New insights into mechanisms of fibrosis in immune renal injury. Springer Semin. Immunopathol. 24: 459-476.
16. Hill, G. S., M. Delahousse, D. Nochy, E. Thervet, F. Vrtovsnik, P. Remy, D. Glotz, and J. Bariety. 2002. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy. Kidney Int. 61: 2176-2186.
17. Ravinal, R. C., R. S. Costa, T. M. Coimbra, M. T. Pastorello, E. B. Coelho, M. Dantas, and R. M. dos. 2002. Classes, activity and chronicity indices, and α-smooth muscle actin expression as prognostic parameters in lupus nephritis outcome. Lupus 11: 82-87.
18. Daniel, L., H. Sichez, R. Giorgi, B. Dussol, D. Figarella-Branger, J. F. Pellissier, and Y. Berland. 2001. Tubular lesions and tubular cell adhesion molecules for the prognosis of lupus nephritis. Kidney Int. 60: 2215-2221.
19. Border, W. A., S. Okuda, L. R. Languino, M. B. Sporn, and E. Ruoslahti. 1990. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β 1. Nature 346: 371-374.
20. Yamamoto, T., N. A. Noble, D. E. Miller, and W. A. Border. 1994. Sustained expression of TGF-β 1 underlies development of progressive kidney fibrosis. Kidney Int. 45: 916-927.
21. Yoshioka, K., T. Takemura, K. Murakami, M. Okada, S. Hino, H. Miyamoto, and S. Maki. 1993. Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab. Invest. 68: 154-163.
22. Braley-Mullen, H., K. Chen, Y. Wei, and S. Yu. 2001. Role of TGF-β in development of spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Immunol. 167: 7111-7118.
23. Kopp, J. B., V. M. Factor, M. Mozes, P. Nagy, N. Sanderson, E. P. Bottinger, P. E. Klotman, and S. S. Thorgeirsson. 1996. Transgenic mice with increased plasma levels of TGF-β 1 develop progressive renal disease. Lab. Invest. 74: 991-1003.
24. Hahn, B. H., and R. R. Singh. 2007. Animal models of systemic lupus erythematosus. In Dubois' Lupus Erythematosus, 7th Ed. D. J. Wallace and B. H. Hahn, eds. Lippincott Williams and Wilkins, Philadelphia, pp. 299-355.
25. Singh, R. R., F. M. Ebling, D. A. Albuquerque, V. Saxena, V. Kumar, E. H. Giannini, T. N. Marion, F. D. Finkelman, and B. H. Hahn. 2002. Induction of autoantibody production is limited in nonautoimmune mice. J. Immunol. 169: 587-594.
26. Singh, R. R., B. H. Hahn, and E. E. Sercarz. 1996. Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity. J. Exp. Med. 183: 1613-1621.
27. De Albuquerque, D. A., V. Saxena, D. E. Adams, G. P. Boivin, H. I. Brunner, D. P. Witte, and R. R. Singh. 2004. An ACE inhibitor reduces Th2 cytokines and TGF-β1 and TGF-β2 isoforms in murine lupus nephritis. Kidney Int. 65: 846-859.
28. Zhang, Y., L. L. McCormick, S. R. Desai, C. Wu, and A. C. Gilliam. 2002. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J. Immunol. 168: 3088-3098.
29. Ling, H., X. Li, S. Jha, W. Wang, L. Karetskaya, B. Pratt, and S. Ledbetter. 2003. Therapeutic role of TGF-β-neutralizing antibody in mouse cyclosporin A nephropathy: morphologic improvement associated with functional preservation. J. Am. Soc. Nephrol. 14: 377-388.
30. Fan, G. C., and R. R. Singh. 2002. Vaccination with minigenes encoding V(H)-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus. J. Exp. Med. 196: 731-741.
31. Yang, J. Q., V. Saxena, H. Xu, L. Van Kaer, C. R. Wang, and R. R. Singh. 2003. Repeated α-galactosylceramide administration results in expansion of NK T cells and alleviates inflammatory dermatitis in MRL-lpr/lpr mice. J. Immunol. 171: 4439-4446.
32. Hill, G. S., M. Delahousse, D. Nochy, E. Tomkiewicz, P. Remy, F. Mignon, and J. P. Mery. 2000. A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int. 58: 1160-1173.
33. Shi, Y., and J. Massague. 2003. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113: 685-700.
34. Ohtsuka, K., J. D. Gray, F. P. Quismorio, Jr., W. Lee, and D. A. Horwitz. 1999. Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-β. Lupus 8: 95-102.
35. Horwitz, D. A., J. D. Gray, and S. G. Zheng. 2002. The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases. Arthritis Res. 4: 241-246.
36. + T cells in lupus-prone (NZB x NZW) F1 mice and healthy (BALB/c x NZW) F1 mice may influence autoimmunity in the lupus model. Eur. J. Immunol. 34: 2489-2499.
37. Ziyadeh, F. N., B. B. Hoffman, D. C. Han, M. C. Iglesias-De La Cruz, S. W. Hong, M. Isono, S. Chen, T. A. McGowan, and K. Sharma. 2000. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice. Proc. Natl. Acad. Sci. USA 97: 8015-8020.
38. Benigni, A., C. Zoja, D. Corna, C. Zatelli, S. Conti, M. Campana, E. Gagliardini, D. Rottoli, C. Zanchi, M. Abbate, et al. 2003. Add-on anti-TGF-β antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat. J. Am. Soc. Nephrol. 14: 1816-1824.
39. Islam, M., J. F. Burke, Jr., T. A. McGowan, Y. Zhu, S. R. Dunn, P. McCue, J. Kanalas, and K. Sharma. 2001. Effect of anti-transforming growth factor-β antibodies in cyclosporine-induced renal dysfunction. Kidney Int. 59: 498-506.
40. Belghith, M., J. A. Bluestone, S. Barriot, J. Megret, J. F. Bach, and L. Chatenoud. 2003. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9: 1202-1208.
41. Huaux, F., T. Liu, B. McGarry, M. Ullenbruch, and S. H. Phan. 2003. Dual roles of IL-4 in lung injury and fibrosis. J. Immunol. 170: 2083-2092.
42. Gorelik, L., P. E. Fields, and R. A. Flavell. 2000. Cutting edge: TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression. J. Immunol. 165: 4773-4777.